Founder Justin Byers, who also started Axio BioPharma, created the company to help innovators find pre-seed and seed stage funding to get their ideas off the ground, he said in a LinkedIn post.
The new fund will focus on companies developing new therapies, tools and technologies that move health care forward.
See the company’s website.